{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:36:55Z","timestamp":1788863815552,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YBKA202209"],"award-info":[{"award-number":["YBKA202209"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["JYLJ202301"],"award-info":[{"award-number":["JYLJ202301"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272288"],"award-info":[{"award-number":["82272288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472577"],"award-info":[{"award-number":["82472577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jvsv.2025.102352","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:10:57Z","timestamp":1762416657000},"page":"102352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of bleomycin polidocanol foam versus absolute ethanol for sclerotherapy of venous malformations"],"prefix":"10.1016","volume":"14","author":[{"given":"Jiayi","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2025.102352_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cps.2010.08.012","article-title":"Pathogenesis of vascular anomalies","volume":"38","author":"Boon","year":"2011","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib2","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms23042358","article-title":"ISSVA classification of vascular anomalies and molecular biology","volume":"23","author":"Kunimoto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jvsv.2025.102352_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/a-0620-8925","article-title":"Vascular anomalies (Part I): classification and diagnostics of vascular anomalies","volume":"190","author":"Sadick","year":"2018","journal-title":"Rofo"},{"key":"10.1016\/j.jvsv.2025.102352_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.sempedsurg.2020.150976","article-title":"Venous malformations","volume":"29","author":"Cooke-Barber","year":"2020","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib5","first-page":"456","article-title":"Venous malformations","volume":"62","author":"Markovic","year":"2021","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jvsv.2025.102352_bib6","doi-asserted-by":"crossref","first-page":"195e","DOI":"10.1097\/01.prs.0000304607.29622.3c","article-title":"Vascular malformations","volume":"121","author":"Arneja","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006534-199907000-00002","article-title":"Sclerotherapy of craniofacial venous malformations: complications and results","volume":"104","author":"Berenguer","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jvsv.2022.08.004","article-title":"A systematic review and network meta-analysis of the effectiveness of sclerotherapy for venous malformation","volume":"11","author":"Cao","year":"2023","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvsv.2025.102352_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1067\/mva.2003.91","article-title":"Advanced management of venous malformation with ethanol sclerotherapy: mid-term results","volume":"37","author":"Lee","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jvir.2022.09.001","article-title":"Factors affecting adverse events after venous malformation sclerotherapy","volume":"33","author":"Lee","year":"2022","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvsv.2025.102352_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/01.RVI.0000124949.24134.CF","article-title":"Percutaneous treatment of low flow vascular malformations","volume":"15","author":"Burrows","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvsv.2025.102352_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jvs.2010.07.019","article-title":"Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations","volume":"53","author":"Yang","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00270-018-1999-8","article-title":"Patient-Reported outcomes of Bleomycin sclerotherapy for low-flow vascular malformations and predictors of improvement","volume":"41","author":"Horbach","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvsv.2025.102352_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2015.04.012","article-title":"Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions","volume":"97","author":"Della Latta","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jvsv.2025.102352_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00383-003-1058-6","article-title":"Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations","volume":"19","author":"Muir","year":"2004","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jvsv.2025.102352_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jvsv.2019.11.022","article-title":"Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations","volume":"8","author":"Yang","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvsv.2025.102352_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejvs.2020.01.023","article-title":"Bleomycin Polidocanol Foam (BPF) stability - in vitro evidence for the effectiveness of a novel sclerosant for venous malformations","volume":"59","author":"Sun","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jvsv.2022.06.005","article-title":"Comparison of polidocanol foam versus bleomycin polidocanol foam for treatment of venous malformations","volume":"11","author":"He","year":"2023","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvsv.2025.102352_bib19","article-title":"Comparison of bleomycin polidocanol foam vs electrochemotherapy combined with polidocanol foam for treatment of venous malformations","volume":"12","author":"Liu","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvsv.2025.102352_bib20","article-title":"Updated classification of vascular anomalies. A living document from the International Society for the Study of Vascular Anomalies Classification Group","volume":"6","author":"Goldenberg","year":"2025","journal-title":"J Vasc Anom"},{"key":"10.1016\/j.jvsv.2025.102352_bib21","first-page":"58","article-title":"Preliminary experience with a new sclerosing foam in the treatment of varicose veins","volume":"27","author":"Tessari","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02563895","article-title":"How I do it. Arteriovenous malformation management","volume":"19","author":"Yakes","year":"1996","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvsv.2025.102352_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1592077","article-title":"Efficacy of embolo\/sclerotherapy in the treatment of high-output cardiac failure caused by peripheral arteriovenous malformations","volume":"12","author":"Guo","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jvsv.2025.102352_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2022.10.011","article-title":"Adverse event classification: clarification and validation of the Society of Interventional Radiology Specialty\u2013specific system","volume":"34","author":"Baerlocher","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvsv.2025.102352_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijpharm.2014.11.056","article-title":"Properties of polidocanol foam in view of its use in sclerotherapy","volume":"478","author":"Nastasa","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jvsv.2025.102352_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/DSS.0000000000003520","article-title":"Polidocanol: a review of off-label dermatologic uses","volume":"48","author":"Nguyen","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.139.11.1409","article-title":"Treatment of venous malformations with sclerosant in microfoam form","volume":"139","author":"Cabrera","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvsv.2025.102352_bib28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jvir.2015.05.007","article-title":"Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling","volume":"26","author":"Ul","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvsv.2025.102352_bib29","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/lary.26077","article-title":"Foamed bleomycin sclerosis of airway venous malformations: the role of interspecialty collaboration","volume":"126","author":"Azene","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvsv.2025.102352_bib30","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/hed.21652","article-title":"Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation","volume":"33","author":"Hu","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.jvsv.2025.102352_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOO.0000000000000376","article-title":"Latest advances in the management of facial synkinesis","volume":"25","author":"Markey","year":"2017","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hed.21410","article-title":"Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy","volume":"33","author":"Spence","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.jvsv.2025.102352_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0284185117741774","article-title":"Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol","volume":"59","author":"Weitz-Tuoretmaa","year":"2018","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jvsv.2025.102352_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bjps.2012.09.002","article-title":"Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them","volume":"66","author":"Odeyinde","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jvsv.2025.102352_bib35","first-page":"8","article-title":"Sciatic neuropathy following endovascular treatment of a limb vascular malformation","volume":"1","author":"Ney","year":"2006","journal-title":"J Brachial Plex Peripher Nerve Inj"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X25001878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X25001878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:36:20Z","timestamp":1773873380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X25001878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213333X25001878"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2025.102352","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of bleomycin polidocanol foam versus absolute ethanol for sclerotherapy of venous malformations","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2025.102352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHOR(S). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"102352"}}